Structure |
Chemical Name |
CAS |
MF |
![6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル](/CAS/20180703/GIF/1059630-08-8.gif) |
6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル |
1059630-08-8 |
C14H17BrN2O2 |
![diphenhydramine impurity](/CAS/20180703/GIF/CB83144868.gif) |
diphenhydramine impurity |
|
C17H21NO |
![1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide](/CAS/20180703/GIF/CB83146796.gif) |
1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide |
|
C18H23IN4S |
![2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid](/CAS/20180703/GIF/1657014-33-9.gif) |
2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid |
1657014-33-9 |
C16H16N2O3S |
![vildagliptin Impurity O](/CAS/20200611/GIF/2253194-12-4.gif) |
vildagliptin Impurity O |
2253194-12-4 |
C12H18N4O2 |
![methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/38990-17-9.gif) |
methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
38990-17-9 |
C21H26N2O3 |
![Canagliflozin Impurity 17](/CAS/20210111/GIF/1951467-28-9.gif) |
Canagliflozin Impurity 17 |
1951467-28-9 |
C24H23FO6S |
![Canagliflozin Impurity 22](/) |
Canagliflozin Impurity 22 |
|
|
![Carfilzomib Impurity 3](/) |
Carfilzomib Impurity 3 |
|
|
![Dolutegravir Impurity 4](/) |
Dolutegravir Impurity 4 |
|
|
![Febuxostat Impurity 20](/) |
Febuxostat Impurity 20 |
|
|
![Lenvatinib Impurity 1](/) |
Lenvatinib Impurity 1 |
|
|
![methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20211123/GIF/83508-82-1.gif) |
methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
83508-82-1 |
C21H26N2O3 |
![4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester](/CAS/20180703/GIF/1941177-45-2.gif) |
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester |
1941177-45-2 |
C29H37N7O3 |
![Cabozantinib impurity 1](/CAS/20200611/GIF/748707-58-6.gif) |
Cabozantinib impurity 1 |
748707-58-6 |
C17H16N2O3 |
![Amlodipine Impurity 19](/CAS/20180703/GIF/CB83159169.gif) |
Amlodipine Impurity 19 |
|
C26H31ClN2O8S |
![Amlodipine Impurity 9](/CAS/20180703/GIF/CB83159174.gif) |
Amlodipine Impurity 9 |
90445-05-9 |
C26H31ClN2O8S |
![Clopidogrel Impurity 7](/CAS/20180601/GIF/444728-13-6.gif) |
Clopidogrel Impurity 7 |
444728-13-6 |
C15H15ClN2OS |
![Rivaroxaban Impurity 36](/CAS/20210305/GIF/1770812-39-9.gif) |
Rivaroxaban Impurity 36 |
1770812-39-9 |
C19H17Cl2N3O5S |
![(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate](/CAS/20180601/GIF/1111177-24-2.gif) |
(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate |
1111177-24-2 |
C20H23N5O2 |
![Clopidogrel Impurity C](/CAS/20180601/GIF/1346605-15-9.gif) |
Clopidogrel Impurity C |
1346605-15-9 |
C16H18ClNO2S |
![Nilotinib genotoxic impurity 2](/CAS/20180906/GIF/1157857-29-8.gif) |
Nilotinib genotoxic impurity 2 |
1157857-29-8 |
C19H15F3N4O3 |
![N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン](/CAS/20180808/GIF/1453221-45-8.gif) |
N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン |
1453221-45-8 |
C35H41F6N3O6 |
![Gliclazide Impurity E](/) |
Gliclazide Impurity E |
|
|
![Ethyl 1-butanesulfonate](/CAS/20180601/GIF/2374-68-7.gif) |
Ethyl 1-butanesulfonate |
2374-68-7 |
C6H14O3S |
![OLANEXIDINE intermediate](/CAS/20180808/GIF/60852-95-1.gif) |
OLANEXIDINE intermediate |
60852-95-1 |
C10H20N4 |
![1H-Isoindole, octahydro-, trans-](/CAS/20180601/GIF/10479-63-7.gif) |
1H-Isoindole, octahydro-, trans- |
10479-63-7 |
C8H15N |
![1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI)](/CAS/20180601/GIF/155272-03-0.gif) |
1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |
155272-03-0 |
C18H20N4O4 |
![Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)-](/CAS/20180601/GIF/181289-34-9.gif) |
Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)- |
181289-34-9 |
C9H17NO3 |
![4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate](/CAS/20180601/GIF/65141-48-2.gif) |
4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate |
65141-48-2 |
C8H10N4O7 |
![2-(ACETOXYMETHYL)-4-METHOXY-3,5-DIMETHYLPYRIDINE](/CAS/GIF/91219-90-8.gif) |
2-(ACETOXYMETHYL)-4-METHOXY-3,5-DIMETHYLPYRIDINE |
91219-90-8 |
C11H15NO3 |
![4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE](/CAS/GIF/112809-52-6.gif) |
4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE |
112809-52-6 |
C17H11N5 |
![Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)-](/CAS/20180601/GIF/93239-37-3.gif) |
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- |
93239-37-3 |
C24H30O5 |
![Tadalafil EP impurity E](/) |
Tadalafil EP impurity E |
|
|
![4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine](/CAS/20200611/GIF/134965-85-8.gif) |
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine |
134965-85-8 |
C12H7ClN6 |
![(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile](/CAS/GIF/914070-99-8.gif) |
(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile |
914070-99-8 |
C7H11N3O |
![1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea](/CAS/20180601/GIF/1388858-78-3.gif) |
1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea |
1388858-78-3 |
C19H23FN2O2 |
![1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one](/CAS/20200401/GIF/220182-11-6.gif) |
1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one |
220182-11-6 |
C10H20N4O |
![Ropivacaine EP Impurity D](/CAS/20200611/GIF/98626-59-6.gif) |
Ropivacaine EP Impurity D |
98626-59-6 |
C16H24N2O |
![Bendamustine Impurity 16](/CAS/20200611/GIF/914626-65-6.gif) |
Bendamustine Impurity 16 |
914626-65-6 |
C19H18N6O4 |
![(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride](/CAS/20180601/GIF/959392-22-4.gif) |
(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride |
959392-22-4 |
C18H19NOS |
![phenyl (R)-methyl(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)carbamate](/CAS/20180703/GIF/CB83358832.gif) |
phenyl (R)-methyl(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)carbamate |
603996-87-8 |
C8H11NO2S |
![Canagliflozin impurity H](/) |
Canagliflozin impurity H |
|
|
![Cefazolin Impurity 9](/CAS/20180808/GIF/1322626-65-2.gif) |
Cefazolin Impurity 9 |
1322626-65-2 |
C14H15N9O3S3 |
![Dapagliflozin Impurity 20](/CAS/20211123/GIF/2040305-09-5.gif) |
Dapagliflozin Impurity 20 |
2040305-09-5 |
C29H33ClO10 |
![Edaravone Impurity 10](/CAS/20200611/GIF/710307-89-4.gif) |
Edaravone Impurity 10 |
710307-89-4 |
C10H12N2O2 |
![Empagliflozin Impurity 23](/) |
Empagliflozin Impurity 23 |
|
|
![Entecavir Impurity 3](/CAS/20200611/GIF/1391053-94-3.gif) |
Entecavir Impurity 3 |
1391053-94-3 |
C12H15N5O4 |
![IBrutinib Impurity C](/) |
IBrutinib Impurity C |
|
|
![Imatinib impurity 12](/) |
Imatinib impurity 12 |
|
|
![Isavuconazole Impurity 20](/) |
Isavuconazole Impurity 20 |
|
|
![Isavuconazole Impurity 26](/) |
Isavuconazole Impurity 26 |
|
|
![Istradefylline impurity D](/) |
Istradefylline impurity D |
|
|
![Leuprorelin EP Impurity F](/CAS/20210111/GIF/1872435-00-1.gif) |
Leuprorelin EP Impurity F |
1872435-00-1 |
C59H84N16O12 |
![Dapagliflozin Impurity 10](/CAS/20200611/GIF/461432-27-9.gif) |
Dapagliflozin Impurity 10 |
461432-27-9 |
C21H25ClO7 |
![Levetiracetam impurity 2](/CAS/20200515/GIF/1341459-52-6.gif) |
Levetiracetam impurity 2 |
1341459-52-6 |
C8H17N3O2 |
![(S)-5-chloro-N-(3-(5-chlorothiophene-2-carboxamido)-2- hydroxypropyl)-N-(4-(3-oxomorpholino)phenyl)thiophene-2- carboxamide](/CAS/20200611/GIF/2204368-63-6.gif) |
(S)-5-chloro-N-(3-(5-chlorothiophene-2-carboxamido)-2- hydroxypropyl)-N-(4-(3-oxomorpholino)phenyl)thiophene-2- carboxamide |
2204368-63-6 |
C23H21Cl2N3O5S2 |
![Ezetimibe Impurity 38](/CAS/20210111/GIF/1701462-59-0.gif) |
Ezetimibe Impurity 38 |
1701462-59-0 |
C45H58F2N2O5Si2 |
![Indapamide Impurity F](/CAS/20210111/GIF/62574-66-7.gif) |
Indapamide Impurity F |
62574-66-7 |
C7H3Cl3O3S |
![Moxifloxacin Impurity 38](/CAS/20200515/GIF/1262758-66-6.gif) |
Moxifloxacin Impurity 38 |
1262758-66-6 |
C21H24FN3O5 |
![Nimodipine Impurity 3](/CAS/20210111/GIF/101072-61-1.gif) |
Nimodipine Impurity 3 |
101072-61-1 |
C11H9NO5 |
![Pitavastatin Impurity 40](/) |
Pitavastatin Impurity 40 |
|
|
![Ritonavir EP Impurity R](/) |
Ritonavir EP Impurity R |
|
|
![Ticagrelor Impurity 68](/CAS/20210111/GIF/1643378-46-4.gif) |
Ticagrelor Impurity 68 |
1643378-46-4 |
C23H29FN6O4S |
![Tofacitinib Impurity 70](/) |
Tofacitinib Impurity 70 |
|
|
![Amifostine Impurity 6](/) |
Amifostine Impurity 6 |
|
|
![Aztreonam Impurity 6](/) |
Aztreonam Impurity 6 |
|
|
![Clarithromycin Impurity EP G](/CAS/20211123/GIF/107216-09-1.gif) |
Clarithromycin Impurity EP G |
107216-09-1 |
C39H72N2O13 |
![Dapagliflozin Impurity 32](/) |
Dapagliflozin Impurity 32 |
|
|
![Doxofylline Impurity 7](/CAS/20200611/GIF/43135-57-5.gif) |
Doxofylline Impurity 7 |
43135-57-5 |
C13H20N4O4 |
![Erlotinib Impurity 55](/) |
Erlotinib Impurity 55 |
|
|
![Etoposide Impurity 1](/) |
Etoposide Impurity 1 |
|
|
![Etoposide Impurity 6](/) |
Etoposide Impurity 6 |
|
|
![Olaparib Impurity 34](/) |
Olaparib Impurity 34 |
|
|
![Oseltamivir Impurity 15](/CAS/20210111/GIF/2254819-34-4.gif) |
Oseltamivir Impurity 15 |
2254819-34-4 |
C22H36N2O4 |
![Oseltamivir Impurity 27](/) |
Oseltamivir Impurity 27 |
|
|
![Pitavastatin Impurity 20](/) |
Pitavastatin Impurity 20 |
|
|
![Rocuronium Bromide Impurity 20](/) |
Rocuronium Bromide Impurity 20 |
|
|
![Rocuronium Bromide Impurity 9](/) |
Rocuronium Bromide Impurity 9 |
|
|
![Verapamil Impurity N](http://CAS/20200331/GIF/2086274-75-9.gif) |
Verapamil Impurity N |
2086274-75-9 |
C33H47N3O4 |
![Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)-](/CAS/20210111/GIF/478-83-1.gif) |
Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)- |
478-83-1 |
C16H15BrN2O2 |
![Dextrorotation lansoprazole Impurity J](/) |
Dextrorotation lansoprazole Impurity J |
|
|
![Dextrorotation lansoprazole-N-oxide](/) |
Dextrorotation lansoprazole-N-oxide |
|
|
![lansoprazole Impurity 23](/) |
lansoprazole Impurity 23 |
|
|
![lansoprazole Impurity 29](/) |
lansoprazole Impurity 29 |
|
|
![Loratadine Impurity L](/CAS/20200119/GIF/CB24841777.gif) |
Loratadine Impurity L |
|
C22H23ClN2O2 |
![meta-dyhydroxy Sugammadex sodium Impurity 1](/) |
meta-dyhydroxy Sugammadex sodium Impurity 1 |
|
|
![Olanzapine impurity R](/CAS/20200119/GIF/CB24841818.gif) |
Olanzapine impurity R |
|
C17H20N4S |
![Palbociclib Impurity 33](/) |
Palbociclib Impurity 33 |
|
|
![Pramipexole Related Impurity 1](/) |
Pramipexole Related Impurity 1 |
|
|
![Ropivacaine Impurity 37](/) |
Ropivacaine Impurity 37 |
|
|
![Ropivacaine Impurity 42](/) |
Ropivacaine Impurity 42 |
|
|
![Sugammadex sodium Org197339-1 Impurity](/) |
Sugammadex sodium Org197339-1 Impurity |
|
|
![Fludarabine EP impurity G](/CAS/20210111/GIF/548774-56-7.gif) |
Fludarabine EP impurity G |
548774-56-7 |
C10H12ClFN5O6P |
![Sitagliptin Impurity 12](/CAS/20210111/GIF/1803026-54-1.gif) |
Sitagliptin Impurity 12 |
1803026-54-1 |
C16H12F6N4O |
![Butyphthalide impurity 44](/CAS/20210111/GIF/952413-01-3.gif) |
Butyphthalide impurity 44 |
952413-01-3 |
C13H18O3 |
![Cabozantinib impurity 24](/) |
Cabozantinib impurity 24 |
|
|
![Celecoxib Impurity 18](/CAS/20200119/GIF/CB24842244.gif) |
Celecoxib Impurity 18 |
2271123-54-5 |
C11H9F3O2 |
![Dapoxetine impurity 22](/) |
Dapoxetine impurity 22 |
|
|
![Febuxostat Impurity 85](/) |
Febuxostat Impurity 85 |
|
|